so very promising data on the also because the scene doesn't have to be stored as cold as the pfizer bio and take alternative that was introduced a little earlier. now the next steps are that the f.d.a. will meet with its advisory committee on december 17th, where they will review this application on december 10th already for the pfizer bio and take vaccine. so we earlier than that, and they are expected to grant emergency use authorization for both. that seems just a little while after that. probably one or 2 days later. so we might look around december 20th. so when could we see the 1st vaccinations actually taking place in the u.s.? so according to any fall to the leading expert for infectious diseases here in the united states, that could happen as soon as the 2nd half of december. now of course there's a little problem, not everyone can be vaccinated at the same time. so the question who will be vaccinated 1st is crucial, and that will be tackled in accordance with recommendations of the center for disease control here in the u.s. . and that is likely going to be medical workers, do

it's worrying that pfizer bio n tech has already struck deals with rich countries for more than a 1000000000 doses of its vaccine, leaving less than a quarter of its projected supply for the rest of the world. big pharma profits must not be prioritized over the health of billions. now, the european commission has been clear and member states can decide what to do with their vaccine doses. and that includes the option of to meeting them to lower and, middle income countries. the u., it's unlikely to help a lot because it is in deep trouble itself. and many poor countries are not going to be able to be all the support it spends if coaching, infrastructure, and storage on time to deliver the missing. this vaccine needs to be stored at minus 70 degree celsius, requiring a special freezer of the type that isn't widely available even in europe and america. meaning countries will have to build deep freeze storage and transportation networks from scratch to keep the vaccine from becoming useless. its production is costly, its component is unstable. it also requires call chain transportation and has

the news that the pfizer bio and texaco had vaccine had shown 90 percent effectiveness in early trials. led to a bounce on the stock markets in a rush of orders from across the world. the u.k. had already preordered 40000000 doses. the european union will sign a deal for 300000000 doses on wednesday, and germany says it hopes to finalize a deal for 100000000 doses in the coming days. we don't know really how well this actually works in older people will ask to see if there are enough data to tell us that pregnant women have been studies, studies that children are just beginning well, long journeys 1st steps. that's wonderful. it looks as though we're making progress, but in africa and asia, lower and middle income countries are looking on in dismay. they're part of a joint initiative called kovacs, which relies on the financial support of richer countries and in the race to vaccinate. charity apparently begins at home, wealthier nations representing just 13 percent of the world's population have already preordered 51 percent of the production of the leading covert vaccine candidates ar

product to be the 2nd vaccine likely to receive special authorization after one developed by pfizer and bio intent are joining me now is young. it's not says he is with the european public health alliance. he is a board member of the european medicines agency, may, which is dealing with his request for authorization here in europe. mr. nazis is good to have you on the program. we want to be clear, you're not speaking on behalf of email, but you do know the procedures there. when do you think madonna will be granted approval? thank you very much for having me. well, that remains to be seen. we've seen in recent weeks, a lot of these press releases from several pharmaceutical companies. we've seen candidates, but pharmaceutical companies press release is not necessarily science. it can be marketing but is not science. so where this very critical point right now, where the regulators, for instance, the european medicines agency in europe, needs to look at all the data and come to its own conclusions on whether or not and when authorize these products and to provide these and the grounds that t

pfizer's drug adding. they had also made deals with other drug makers. and i assume that with bio intact, as announced yesterday, that you commission president miss vanderlei and we will be able to bring the negotiations to a conclusion very quickly. in any case, the mention of at least 200000000 doses for the european union is secured. now it just has to be finally secured in the contract. and meanwhile, bio in texas head of strategy. ryan richardson was asked about profiting from the development of a drug that received funding from the german government during a financial times conference on tuesday, saying the vaccine will be priced quote, well below typical market rates. so with all of this in mind, let's go ahead and take a look at the trends and spread of the virus globally with our t. correspondent science having your side. where are we today? brand another bad day as they reach 51000000 confirmed cases worldwide. now the u.s. has already surpassed 10000000 and confirmed cases and global debts were at 1.275000025 percent of which from the deaths are coming just from the u.s

and following the news that pfizer bio and texaco but 1000 vaccine candidate showed an efficacy. of 90 percent the european commission will sign a deal to secure up to 300000000 doses of the experimental drug the president of the european commission said they will authorize the deal on wednesday after quote working tirelessly to secure doses of a potential vaccine in the last few months german health minister yes on tuesday had confirmed the block was ready to secure at least 200000000 doses of pfizer's drug adding they had also made deals with other drug makers. and i assume that with bio intact as announced yesterday that you commission president miss vanderlei and we will be able to bring the negotiations to a conclusion very quickly in any case the mention of at least 200000000 doses for the european union is secured now it just has to be finally secured in the contract . and meanwhile biotech's head of strategy ryan richardson was asked about profiting from the development of a drug that received funding from the german government during a financial times conference on tuesd

but as we know in the last 10 days, the pfizer bio and tech and the medinah vaccines have pulled ahead and, and have shown that they are more than 90 percent effective. and was in thing is that those vaccines use a technology that is completely new, that known as messenger r n a, but their results are not. so vaccine results are very promising for all the other vaccines that are still in development. but so much more than a quarter of a 1000000 people who died from the covert. 19 in the u.s. nots, the highest number of deaths in a single country infections are still rising. more than a 1000000 cases have been reported in the past week. the situation so bad that states and cities are imposing new restrictions. york city has just decided to close schools to prevent more infection. until the very latest while white house correspondent, kimberly how could 2000 washington d.c. completed in 50000 kroner virus related deaths in the u.s. . it's a grim milestone and experts obviously warning that the death rate could increase and swearing because it's a major holiday on the horizon. yeah, thing

know we know that this is going to be fast tracked for approval along with the madonna and the the pfizer bio intake are in a vaccines. and the hope is that very soon, and that will be probably early in the new year in the u.k. anyway, vaccine vaccination can start, but of calls, you have a real challenge with all these vaccines. one of them, of course, is manufacturing. and the 2nd one is how you put in the infrastructure to make sure that you can cover a large portion of your population with a vaccine. and this is going to be the next set of challenges. but all of this together is very, very good news. and as the world health authority has said, organizations said this morning is really encouraging news that makes us all very optimistic was recognizing that we still got to be very careful about this virus. one of the other challenges we've been talking about recently with the other vaccines is how they're to be stored and then transported as well. not the u.k. vaccine doesn't have to be stored at ultra cold temperatures. could that be a game changer? i think it could not think that what wil

but as we know in the last 10 days, the pfizer bio and tech and the medinah vaccines have pulled ahead and, and have shown that they are more than 90 percent effective. and was in thing is that those vaccines use a technology that is completely new, that known as messenger r n a. but their results are not for vaccine results are very promising for all the other vaccines that are still in development. now doctors in syria's last rebel stronghold are warning of catastrophic consequences of covert 19 in italy province . the u.n. says daily inspections have increased by 300 percent in the last month. the reports it province has been battered by the syrian conflict. now in its 10th year, the last rebel controlled glave in the northwest is home to nearly 4000000. people most depend on aid to survive and many live in makeshift shelters in camps for the displaced it live reported its 1st coronavirus infection in july. since then, the number of people infected has increased rapidly to 11 and a half 1000 a day. this on my last 5 to 10 years of dealing with bombing casualties and the targeting of

but as we know in the last 10 days, the pfizer bio and tech and the madonna vaccines have pulled ahead and, and have shown that they are more than 90 percent effective. and was in thing is that those vaccines use a technology that is completely new, that known as messenger r n a, but their results are not. so vaccine results are very promising for all the other vaccines that are still in development. well, as i mentioned, coronavirus cases in africa has passed. 2000000 armitage's has been following the story from nigeria's capital. this seems to be some for tea or some kind of fatigue of the past 2 of africans. we just came back from an election in ivory coast and what you notice there in, across many sub-saharan african countries is that people where very few people wear masks this days. social distancing is still a problem, and crowds gather in large numbers. most of the people you see in such crowds don't wear a face mask. experts are warning that as the how much dusty amateur season kicks in . in a few weeks or a few days. we were going to see we are going to see a lot of cases of

but as we know in the last 10 days, the pfizer bio and tech and the madonna vaccines have pulled ahead and have shown that they are more than 12 percent effective. and what's interesting is that those vaccines use a technology that is completely new, that is messenger r.n.a. . but that result, i don't have vaccine results of very promising for all the other vaccines that are still in development. as we mentioned, more than a quarter of a 1000000, people have now died from cold at 19 in the u.s. . the highest number of deaths in a single country infections are still rising more than a 1000000 cases have been reported in the past week. the situation is so bad, states in cities are imposing new restrictions. new york city has just decided to close schools to prevent more infections. that speaks of it in washington for a skimpily agree milestone 250000 deaths and experts. so warning that the rate of deaths could actually increase in the next few months. yeah, some troubling numbers all add another one to a 25 percent increase in hospitalizations in the last week. and this is what is concer

now to make as pfizer and bio and tech say, they have the capacity to produce nearly $1400000000.00 says by the end of next year, they priced it at just under 40 u.s. dollars for today's course in the u.s. . but they haven't promised to make it available on a not for profit basis. and that's provoked criticism from rights groups, especially as analysts say, it could generate about 3500000000 dollars next year. but by antec has assured buyers, it will be priced well below typical market rates that was definite across the wilds. paul brennan has more on the news that the pfizer bio and tech over vaccine have shown 90 percent effectiveness in early trials. led to a bounce on the stock markets in a rush of orders from across the world. the u.k. had already preordered 40000000 doses. the european union will sign a deal for 300000000 doses on wednesday, and germany says it hopes to finalize a deal for 100000000 doses in the coming days. there is a sense of cautious optimism, despite some lingering questions. we don't know really how well this actually works . and older people will ask to see i

but as we know in the last 10 days, the pfizer bio and tech and the madonna vaccines have pulled ahead and, and have shown that they are more than 90 percent effective. and was in thing, is that those vaccines use a technology that is completely new, that known as messenger r n a, but their results are not. so vaccine results are very promising for all the other vaccines that are still in development. meanwhile, coronavirus infections across africa have risen above 2000000. the world health organization has warned the continent is moving towards a 2nd wave. have been 40000, deaths in africa are linked to covered 19. the united nations says 30000, people have not crossed into sudan from albany. theo p.-a, they're fleeing ongoing violence between federal government forces and the local fighters in the to grave region. there are now over 30000 refugees in sudan, adding that seeing families, their families, and children who have been sleeping in, in the open. the u.n. team where the government sudan is working to ensure their people are not in reception centers for more than 2 days before

and the news that came out on monday absolutely bowled me over, the results from the pfizer bio in-techrial, the interim results suggesting that that vaccine may be as much as 92% effective, that had an enormous impact on me. >> your father, this nation owes a debt to your father and also to you because your father gave the polio vaccine to you and your siblings early on in the testing stages here. when i look at the vaccine for coronavirus, based on what you know now and as an expert yourself, will you get the vaccine once it is made available? >> i want to see what the results look like and the safety profile, but i think absolutely, there is very little doubt in my mind that we're going to end up you with a vaccine that will be effective and i think that not just one vaccine, but many that will be effective and also safe. >> sad fact about where we are right now is that significant portions of the country say they don't trust a vaccine. most recent cnn polling is that about 50% of the population have said that they will take it. of course that is well below what you need to successfu

stocks that have been beaten down this year sky rocketed on news that a vaccine from pfizer and bio andech is more than 90% effective at preventing covid-19. shares of pfizer rode 5% and movies at amc rose 50% and many airlines and cruise lines jumped double damage its. meantime, tech companies like amazon, netflix and peloton that boomed during the pandemic were lower. the ftc is requiring zoom to strengthen the security system. >>> the popular video app is settling allegations it mislead users about the level of protection it head since at least 2016. zoom engaged in unfair practices that undermine the security of its users, according to regulators. >> mcdonald's was loving the last quarter. the fast food giant helped sales spike in the summer and all told, earnings topped $1.7 billion. mcdonald's said it's introducing a chicken sandwich next year and making a plant burger dubbed mcplant. for more, head to cbsmoneywatch.com. i'm diane king hall. >>> it's 4:45 and get a check on weather with mary least it's very cold out there. >> and it is for sure. the cold blast of air, we looking a

the pfizer bio on tech vaccine is said to be 95 percent effective. however, it requires specialist deep freezing. both madonna and pfizer will charge at least $20.00 a dose. jonah, how is in london for so i guess one of the most important questions on the mind of the public journal is when will this astra zeneca vaccine be available? yes, of course. well, after the nick of the british pharmaceutical firm that partnered with the university of oxford in this venture say that they will be submitting these interim results to the regulator immediately in the hope that their vaccine can be improved . approved for a role that potentially by the end of december to the 1st, among the most vulnerable people here in the u.k. given the doses that are currently available. the question of course is which dosage regime the regulators will in fact approve. there is a discrepancy in the results between the standard dosage regime that was used across this very large scale trial. one dose followed by a 2nd full dose a month later, the produced not very encouraging resul

that by the middle of next month, by the summer, we will be having the emergency approval of the pfizer and bio on tax vaccine. and that means they have the capability of $500000000.00 doses to be produced within this year. so basically the capability has already been up and running to produce these vaccines, and they have already made the deal to send countries on defend those. as,, for example, here in the u.k., we had $40000000.00 doses already agreement with these. so as soon as the authorization is done within the middle of next month, meaning that by mid january, the emergency does is going to be distributed to the vulnerable communities and the front line as photographs. but we really what we are looking for the vaccine for you there, because for me is really the 1st quarter of clinical, realistically, how fast can the facts, same be produced in the sufficient quantities that you and i and everybody could be vaccinated and loss returned to normal yeah, very important question and probably a hot debate in coming days is that how quickly we can not only just manufacture but also distribute

but as we know in the last 10 days, the pfizer bio and tech and the madonna vaccines have pulled ahead and, and have shown that they are more than 90 percent effective. and what's interesting is that those vaccines use a technology that is completely new,, that known as messenger r.n.a., but their results are not. so vaccine results are very promising for all the other vaccines that are still in development because the scientists say that if one is working well of 2 it working well, it's very likely that the others will also work well. and that's important because scientists say that it's not, it's going to be a, it's not going to be a one size fits all. one vaccine might be good for a certain age group. another vaccine might be good for certain ethnicity or certain demographic in the population. but all this talk of facts, and it's certainly giving hope here in britain, indeed in london. thank you live in a project for us ahmed. this been an increase in cases in africa over the last few weeks. where is this happening and why? fully the truth of the matter is this seems to be some for

israel signed a deal with drug maker pfizer and bio on to receive 8000000 doses of its coronavirus vaccine next year. new zealand, as we opened downtown oakland of the tracing new coronavirus to a known cluster in germany, it's the time when normally the company's world famous christmas markets would be preparing to open for the holidays, but most of been canceled due to the pandemic. now the one in keep is keeping the tradition alive, but you'll have to buckle up to go and visit a flurry of fake snow welcomes visitors to this atypical german christmas market. in line with the times a drive through one. with many christmas markets in germany canceled this year because of the coronavirus pandemic. the organizer of this one had to come up with a new way to bring about the christmas spirit. the staples of the classic german christmas market are all their sweets grosset, armand's, and cotton candy. but for the visitors, what really counts is the atmosphere. but i heard christmas carols for the 1st time and i'm slowly getting into the mood. but to get into a real christmas mood will take time.

pfizer and bio tech have applied for emergency use of their job in the u.s. and say they're ready for world wide distribution, but it will have to be stored and transported at minus 70 degrees celsius. we have already produced more than 20000000 doses in our cars and to continue as we speak, producing more and more. this is why we said that by the end of the year, which is a matter of how many 5 weeks we expect to actually see medium doses that you can distribute to the world. but their reality is there has never been a drug that requires storage at this temperature. it's a logistical nightmare for rural communities. but now it is me into the challenges distributing the fax scene, photos for the medical industry. very few cargo companies have the capacity to transport goods at minus 70 which is colder than the south pole. in fact, many firms do not even have the facilities to reach minus 20, and that is not the only logistical challenge expected, particularly in poorer and remote areas. pfizer and biotech plan to transport their vaccine in special temperature

today the drug maker pfizer and bio on tech announced promising news about their corona virus vaccine early analysis shows that it is more than 90 percent effective in preventing covert 90 it comes as the number of new infections in the u.s. and here in europe continue to reach new highs tonight good news a ray of light just before the pandemic pushes countries on both sides of the atlantic into what is being called the darkest of winters i'm from berlin this is the day. that we just received positive news in this for the newsweek there's been progress made for success and rushes off a student text message gets across home to some semblance of hope to use. his followers it's clear that this vaccine even if approved will not be widely available for many months yet to come the economy will come back because people will start to feel normal again and challenge before us right now is still man's and growing hopefully we have someone in office who can help us get rid of the pulpit crisis and bring jobs back it's not like people are not working because they don't want to they are having a t

to see you again mr mooney i want to ask you how significant is this news i understand even at pfizer in bio on tech that they were surprised that the results so far are this good. oh yeah absolutely thank you very much for having me on the show i think it is really incredible news particularly of an already speculations were really low i mean if we look on to the expectation of defense regulates the bodies like f.d.a. and they have been expecting 60 to 70 percent action and now it's having 90 put 90 percent of action and of an herbal community is i think this is meeting incredible news on though this 90 percent how's going to make it based on a small number of infection in the volunteers yeah this is a really really convincing start and i understand that we have to wait for the trials to continue incentives that basically pfizer in biotech are waiting to see if anyone gets sick right well yeah absolutely so. the total number of people that are involved in this trial there are only 40 suites follows and at least $164.00 people need to be in fact it's nearly concluded the face retrial and as

now this comes just after a joint project between pfizer and bio and their vaccine has proven to be over 90 percent effective. tell us more about that. yes, we hear that the vaccine that you mentioned. it's a joint germany american production indeed shows very good results. again, these are early results, interim results, but still the developers say it was 90 percent effective, but not everybody is fully convinced because some critical questions still remain unanswered. for example, whether this vaccine entirely prevents infection whether symptomatic areas might still be a cause for concerns in the future. or there was no information, in fact, even on the frequency of side effects or how severe they were. and we have few details on the vaccines safety profile, in fact, and we hear from pfizer. this is one of the companies behind these facts saying that all the data is going to be released in the coming weeks. so this is an ongoing developing story, and of course there are still concerns. there are doubts, there is criticism just like with the russian vaccine. it's understandable, but my

product to be the 2nd vaccine likely to receive special authorization after one developed by pfizer and bio on 10 are joining me now is young. it's not says he is with the european public health alliance. he is, a board member of the european medicines agency, the e.m.e.a., which is dealing with would earn his request for authorization here in europe. mr. not says it's good to have you on the program. we want to be clear, you're not speaking on behalf of him a but you do know the procedures there. when do you think madonna will be granted approval? thank you very much for having me. well, that remains to be seen. we've seen in recent weeks, a lot of these press releases from several pharmaceutical companies. we've seen candidates, but pharmaceutical companies press release is not necessarily science. it can be marketing but is not science. so where it is very critical point right now, where the regulators, for instance, the european medicines agency in europe, needs to look at all the data and come to its own conclusions on whether or not and when to authorize these products and to provide

today the drugmaker pfizer and bio on tech announced promising news about their corona virus vaccine early analysis shows that it is more than 90 percent effective in preventing covert 19 it comes as the number of new infections in the u.s. and here in europe continue to reach new highs tonight good news a ray of light just before the pandemic pushes countries on both sides of the atlantic into what is being called the darkest of winters i'm burnt off in berlin this is the day.

see you again mr mini i want to ask you how significant is this news i understand that even at pfizer in bio on take that they were surprised that the results so far are this good oh yeah absolutely thank you very much for having me on the show i think it is really incredible news particularly when our expectations are really low i mean if we look onto the expectation of if we don't regulate the body like of the 8 you actually have been expecting 60 to 70 percent action and now it's having 9090 percent action in the interval community as i think this is merely incredible news although this 90 percent house can kind of make it based on a small number of infection in the wall and yet yeah this is a really really since talks and i understand that we have to wait for the trials to continue incentives and basically pfizer in biotech are waiting to see if anyone gets sick right. oh yeah absolutely so. the total number of people that are involved in this trial there are 40 sweet fellows and at least $164.00 people need to be infected to nearly conclude the face trial and as it stands now 94 people

the 1st indications could happen by mid december after pfizer in bio in tech specs in can't, it receives emergency approval. so with all of this in mind, let's go ahead and take a look at the trends and spread of the virus globally with r.t. correspondent saya tablature. so where are we on monday? so right now, brian cowen, 1000, is continuing to spread across the world with almost 60000000 cases. in 190 countries and almost 1400000, that's the u.s. . they have the highest number of infections in the world with more than 12000000 cases. and the spread of the virus is showing no signs of slowing down now with just one week of november left to go. the u.s. has already had the highest monthly case total. you know, on sunday we had over $141000.00 cases, which is actually likely much higher since official cowan's are usually slow to report coming out of the weekend. and while this is the 3rd wave that hit the u.s. just this year, one major difference is that this time it's affecting every single region to same time. now take a look here. so at the moment the worst outbreaks are here right he